New Members
For more information about becoming a member please contact: +1 617-324-7756 or email newdigs@mit.edu
Membership Overview
Benefits of NEWDIGS Sponsorship
- Shape the next frontier of innovation policies, processes, and technologies in the global pharmaceutical and healthcare industries.
- Inform strategic priority setting within your organization through insights as they emerge from NEWDIGS activities and discussions.
- Access formal and informal interactions with senior level change agents from across the global biomedical and healthcare innovation ecosystem, as well as the world-class faculty and pipeline of student talent at MIT.
For further information on ways to participate in NEWDIGS call 617-324-7756 or email newdigs@mit.edu
Members and Collaboration Partners
We express thanks to the following members and collaboration partners for their contributions.
- AdaptImmune
- Alliance for Regenerative Medicine
- American College of Rheumatology
- Amgen
- Anthem
- Arthritis Foundation
- AveXis
- Beth Israel Deaconess Medical Center (BIDMC)
- Bill & Melinda Gates Foundation
- BioMarin
- Blue Cross Blue Shield Association
- bluebird bio
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Canadian Agency for Drugs and Technologies in Health (CADTH) ≈
- Canadian Organization for Rare Disorders (CORD)
- Cardinal Health
- CareMetx
- Dana-Farber Cancer Institute
- Editas
- Equity Healthcare
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- European Organisation for Rare Diseases (EURORDIS)
- European Medicines Agency (EMA)
- European network for Health Technology Assessment (EUnetHTA)
- Evidera | PPD
- FasterCures
- Food and Drug Administration (FDA, USA)
- Friends of Cancer Research
- Harvard Business School
- Harvard Medical School
- Harvard-MIT Center for Regulatory Science
- Harvard Pilgrim Healthcare
- Harvard School of Public Health
- Health Canada
- Healthcare Financial Management Association
- Humana
- Huron
- Innovative Medicines Initiative (IMI)
- IQVIA
- Johns Hopkins University
- Johnson & Johnson
- Kaiser Permanente
- Massachusetts General Hospital Cancer
- Massachusetts General Hospital Rheumatology
- Medical Products Agency (MPA, Sweden)
- Medicines and Healthcare products Regulatory Agency (MHRA)
- MedImpact
- Merck & Co., Inc.
- MIT Lincoln Laboratory
- National Healthcare Institute (ZIN, the Netherlands)
- National Hemophilia Foundation
- National Institute for Health and Care Excellence (NICE)
- National Instutes of Health
- National Organization for Rare Disorders (NORD)
- National Pharmaceutical Council (NPC)
- NovoNordisk
- Orchard Therapeutics
- Pfizer
- REGENXBIO
- Sanofi
- Sarepta Therapeutics
- Sun Life Financial
- Tufts Clinical and Translational Science Institute
- Ultragenyx
- United Healthcare
- University of Miami Sylester Comprehensive Cancer Center
Consortium Members in bold
